About Primer Capital
Primer Capital is a private equity firm founded in 2015. It is primarily based in Moscow, Russia.
Overall Primer Capital portfolio has seen 1 IPO, namely Acticor Biotech. A lot of funds co-invest with Primer Capital, with names like Two Sigma Ventures sharing a substantial percentage of its portfolio.
Primer Capital has a team of 8 people, including 3 partners.
Key Metrics
Primer Capital's Portfolio
They have invested in a total of 9 companies. Their most recent investment was in Nelo (Series A round) on Oct 12, 2021. Here is the most recent investment by Primer Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Oct 12, 2021 | Series A | 9201 | ||
Dec 23, 2020 | Series B | 8854 | ||
Jun 13, 2019 | Seed | 6064 | and 2 others | |
Oct 08, 2018 | Seed | 6239 | - |
Here is the portfolio snapshot of Primer Capital:
Investments by Year
The maximum number of investments were made in 2018
Team profile of Primer Capital
Primer Capital has a team of 8 members including 3 Partners and 1 Principal located in Russia, France and 1 more location. Primer Capital's team does not sit on the board of any company as of now.Here is a list of all team members in Primer Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Russia | - | - | |
Partner | Switzerland | - | - | |
Partner | - | - | - | |
Principal | Moscow | - | - | |
Advisor | Paris | - | ||
Advisor | Russia | - | - | |
Advisor | - | - | - | |
Advisor | - | - | - |
Co-investors of Primer Capital
Over the past 11 years, 9 investors have co-invested in Primer Capital's portfolio companies.
- Top Co-investors of Primer Capital: 9 investors entered a company along with Primer Capital. These include investors like Two Sigma Ventures (1 company).
Primer Capital News
•
•
Russian startup Botkin.AI attracts $1.5 million to better diagnose cancer at early stagesEast-West Digital News•Jun 13, 2019•Botkin.AI, RBV Capital, Orbita Capital Partners, Primer Capital and 1 other
•
•
Advanced multiple myeloma drug candidate gets Russian backingMarchmont Capital Partners•Oct 31, 2017•Primer Capital
•
•
Artificial intelligence supports medical diagnostics | Central regions, Finance, business MarchmontNews.comMarchmont Capital Partners•Aug 03, 2017•Botkin.AI, Primer Capital